Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Acta cir. bras ; 27(9): 600-605, Sept. 2012. ilus
Artigo em Inglês | LILACS | ID: lil-646724

RESUMO

PURPOSE: To investigate the effect of the opioid blocker naltrexone in the inflammatory response in acute pancreatitis (AP). METHODS: Acute pancreatitis was induced in anesthetized male Wistar rats by retrograde injection of 2.5% sodium taurocholate diluted in 0.5ml saline into the main pancreatic duct. Animals were randomized to the following experimental groups: Control Group (n=9): animals received an intraperitoneal injection of saline solution (0.5ml), 15 minutes before the induction of AP. Naltrexone Group (n=9): animals received an intraperitoneal injection of naltrexone 0.5ml (15 mg/kg), 15 minutes before induction of AP. Peritoneal levels of TNF-α and serum levels of IL-6 and amylase were determined The volume of the ascitic fluid was also evaluated. Myeloperoxidase (MPO) activities were analyzed in homogenates of pulmonary tissue. RESULTS: There were no significant differences in the ascitic fluid volume, nor in TNF-a and IL-6 levels in the naltrexone group compared to controls. Treatment with naltrexone did not affect the lung MPO activity compared to control group. CONCLUSIONS: The opioid receptors don't play an important role in the pathogenesis of the inflammatory response in acute pancreatitis. If opioids affect leukocytes inflammatory signaling, there are no major implications in the pathogenesis of acute pancreatitis.


OBJETIVO: Investigar o efeito do bloqueador opióide naltrexone na resposta inflamatória da pancreatite aguda. METODOS: Pancreatite aguda foi induzida em ratos machos Wistar, através de injeção retrógada de solução de taurocolato de sódio a 2,5% nos ductos pancreáticos. Os animais foram alocados em dois grupos: Grupo controle (n=9) animais receberam 0,5 ml de solução salina intra-peritonial 15 minutos antes da indução da pancreatite aguda e Grupo naltrexone (n=9) animais receberam naltrexone (15mg/kg de peso), em 0,5 ml de volume final por via intraperitoneal, 15 minutos antes da indução da pancreatite aguda. Foram avaliados o volume de ascite, os níveis séricos de amilase e IL-6, assim como TNF-α peritoneal e a atividade da mieloperoxidase (MPO) no tecido pulmonar. RESULTADOS: Não foram encontradas diferenças significantes nos parâmetros analisados entre o grupo que recebeu solução salina e o que recebeu naltrexone . CONCLUSÕES: Os receptores opióides não desempenham papel importante na resposta inflamatória sistêmica associada à pancreatite aguda. Se os opioides alteram a sinalização inflamatória nos leucócitos está ação não se reflete na patogênese da pancreatite aguda.


Assuntos
Animais , Masculino , Ratos , Naltrexona/farmacologia , Antagonistas de Entorpecentes/farmacologia , Pancreatite/etiologia , Receptores Opioides/fisiologia , Doença Aguda , Amilases/sangue , Modelos Animais de Doenças , /sangue , Pancreatite/metabolismo , Peroxidase/análise , Distribuição Aleatória , Ratos Wistar , Receptores Opioides/antagonistas & inibidores , Ácido Taurocólico , Fator de Necrose Tumoral alfa/análise
2.
Clinics ; 66(1): 151-157, 2011. ilus, tab
Artigo em Inglês | LILACS | ID: lil-578612

RESUMO

OBJECTIVES: To investigate the effect of opioid receptor blockade on the myocardial protection conferred by chronic exercise and to compare exercise training with different strategies of myocardial protection (opioid infusion and brief periods of ischemia-reperfusion) preceding irreversible left anterior descending coronary ligation. INTRODUCTION: The acute cardioprotective effects of exercise training are at least partly mediated through opioid receptor-dependent mechanisms in ischemia-reperfusion models. METHODS: Male Wistar rats (n = 76) were randomly assigned to 7 groups: (1) control; (2) exercise training; (3) morphine; (4) intermittent ischemia-reperfusion (three alternating periods of left anterior descending coronary occlusion and reperfusion); (5) exercise training+morphine; (6) naloxone (a non-selective opioid receptor blocker) plus morphine; (7) naloxone before each exercise-training session. Myocardial infarction was established in all groups by left anterior descending coronary ligation. Exercise training was performed on a treadmill for 60 minutes, 5 times/week, for 12 weeks, at 60 percent peak oxygen (peak VO2). Infarct size was histologically evaluated. RESULTS: Exercise training significantly increased exercise capacity and ΔVO2 (VO2 peak - VO2 rest) (p<0.01 vs. sedentary groups). Compared with control, all treatment groups except morphine plus naloxone and exercise training plus naloxone showed a smaller infarcted area (p<0.05). No additional decrease in infarct size occurred in the exercise training plus morphine group. No difference in myocardial capillary density (p = 0.88) was observed in any group. CONCLUSIONS: Exercise training, morphine, exercise training plus morphine and ischemia-reperfusion groups had a smaller infarcted area than the control group. The effect of chronic exercise training in decreasing infarct size seems to occur, at least in part, through the opioid receptor stimulus and not by increasing ...


Assuntos
Animais , Masculino , Ratos , Infarto do Miocárdio/prevenção & controle , Condicionamento Físico Animal/fisiologia , Receptores Opioides/antagonistas & inibidores , Estudos de Casos e Controles , Cardiotônicos/farmacologia , Morfina/farmacologia , Infarto do Miocárdio/patologia , Traumatismo por Reperfusão Miocárdica/prevenção & controle , Entorpecentes/farmacologia , Consumo de Oxigênio/fisiologia , Esforço Físico/fisiologia , Distribuição Aleatória , Ratos Wistar , Fatores de Tempo
3.
Yonsei Medical Journal ; : 1016-1021, 2011.
Artigo em Inglês | WPRIM | ID: wpr-116323

RESUMO

PURPOSE: We investigated what kinds of neurotransmitters are related with electroacupuncture (EA) analgesia in an arthritic pain model of rats. MATERIALS AND METHODS: One hundred rats were assigned to six groups: control, EA, opioid, adrenergic, serotonin and dopamine group. A standardized model of inflammatory arthritis was produced by injecting 2% carrageenan into the knee joint cavity. EA was applied to an acupoint for 30 min in all groups except fo the control group. In the opioid, adrenergic, serotonin and dopamine groups, each receptor antagonist was injected intraperitoneally to their respective group before initiating EA. RESULTS: In the opioid receptor antagonist group, adrenergic receptor antagonist group, serotonin receptor antagonist group, dopamine receptor antagonist group and the control group weight-bearing force decreased significantly from 30 min to 180 min after EA in comparison with the EA group. CONCLUSION: The analgesic effects of EA are related to opioid, adrenergic, serotonin and dopamine receptors in an arthritic pain model of rats.


Assuntos
Animais , Masculino , Ratos , Analgesia por Acupuntura/métodos , Antagonistas Adrenérgicos/uso terapêutico , Artrite/induzido quimicamente , Carragenina/toxicidade , Antagonistas de Dopamina/uso terapêutico , Eletroacupuntura/métodos , Neurotransmissores/metabolismo , Dor/tratamento farmacológico , Ratos Sprague-Dawley , Receptores Adrenérgicos/metabolismo , Receptores Dopaminérgicos/metabolismo , Receptores Opioides/antagonistas & inibidores , Receptores de Serotonina/metabolismo , Antagonistas da Serotonina/uso terapêutico
4.
KOOMESH-Journal of Semnan University of Medical Sciences. 2007; 9 (1): 27-32
em Persa | IMEMR | ID: emr-84021

RESUMO

Opiates have complex effects on seizure activity. They have both anti-and proconvulsive effects depend on their concentration. Low doses of morphine have anticonvulsant effects, while high doses have proconvulsant effects. Sudden morphine withdrawal results in shortterm proconvulsant effects. In the present, the effects of opioid receptors agonists and antagonists on spontaneous seizure activity in epileptogenic hippocampal slices were evaluated. Hippocampal slices [400 micro m] were prepared from young Wistar rats [P15-25]. Seizure activity was induced by continuous perfusion of the slices with low-Mg2+ ACSF. Extra cellular recordings were performed in the hippocampal CA1 pyramidal cell layer. Seizure activity was quantified by measuring the amplitude and duration of the ictal events as well as their number after and prior to the application of the agonists and antagonists of the opioid receptors. In addition, the numbers of interictal spikes were determined to complement the analysis of seizure discharges before and after drug application. Our results show that DAMGO and Dyn-A [10 micro M], as micro and kappa-opioid receptor agonist respectively, cause a significant increase in the incidence and amplitude and duration of ictal activity and these effects were completely reversed following the appilcation of B-FNA and nor-BNI [10 micro M] as micro and kappa opioid receptor antagonist respectively. DPDPE [10 micro M], a selective delta-opioid receptor agonist, caused a significant decrease in the incidence and duration of ictal activity and these effects were completely reversed by the addition of NTI [10 micro M], a selective delta opioid receptor antagonist. Our finding showed that epileptic effects of morphine probably are established by activation of micro and kappa opioid receptors and due to the activation of delta opioid receptor, morphine produces antiepileptic effects


Assuntos
Animais de Laboratório , Receptores Opioides/antagonistas & inibidores , Convulsões , Morfina/efeitos adversos , Morfina/administração & dosagem , Hipocampo/fisiologia , Hipocampo/efeitos dos fármacos , Ratos Wistar
5.
Yonsei Medical Journal ; : 167-178, 2006.
Artigo em Inglês | WPRIM | ID: wpr-113995

RESUMO

Alcohol dependence is a chronic disorder that results from a variety of genetic, psychosocial, and environmental factors. Relapse prevention for alcohol dependence has traditionally involved psychosocial and psychotherapeutic interventions. Pharmacotherapy, however, in conjunction with behavioral therapy, is generating interest as another modality to prevent relapse and enhance abstinence. Naltrexone and acamprosate are at the forefront of the currently available pharmacological options. Naltrexone is an opioid receptor antagonist and is thought to reduce the rewarding effect of alcohol. Acamprosate normalizes the dysregulation of N-methyl-D-aspartate (NMDA)-mediated glutamatergic excitation that occurs in alcohol withdrawal and early abstinence.These different mechanisms of action and different target neurotransmitter systems may endow the two drugs with efficacy for different aspects of alcohol use behavior. Since not all patients seem to benefit from naltrexone and acamprosate, there are ongoing efforts to improve the treatment outcomes by examining the advantages of combined pharmacotherapy and exploring the variables that might predict the response of the medications. In addition, novel medications are being investigated to assess their efficacy in preventing relapse and increasing abstinence.


Assuntos
Humanos , Ácido gama-Aminobutírico/metabolismo , Taurina/análogos & derivados , Recidiva , Receptores Opioides mu/genética , Receptores Opioides/antagonistas & inibidores , Polimorfismo Genético , Neurônios/metabolismo , Naltrexona/uso terapêutico , N-Metilaspartato/metabolismo , Modelos Neurológicos , Modelos Biológicos , Glutamina/metabolismo , Dissulfiram/uso terapêutico , Alcoolismo/tratamento farmacológico , Dissuasores de Álcool/uso terapêutico
6.
Braz. j. med. biol. res ; 32(12): 1545-50, Dec. 1999. graf
Artigo em Inglês | LILACS | ID: lil-249382

RESUMO

The widespread consumption of anorectics and combined anorectic + alcohol misuse are problems in Brazil. In order to better understand the interactive effects of ethanol (EtOH) and diethylpropion (DEP) we examined the locomotion-activating effects of these drugs given alone or in combination in mice. We also determined whether this response was affected by dopamine (DA) or opioid receptor antagonists. A total of 160 male Swiss mice weighing approximately 30 g were divided into groups of 8 animals per group. The animals were treated daily for 7 consecutive days with combined EtOH + DEP (1.2 g/kg and 5.0 mg/kg, ip), EtOH (1.2 g/kg, ip), DEP (5.0 mg/kg, ip) or the control solution coadministered with the DA antagonist haloperidol (HAL, 0.075 mg/kg, ip), the opioid antagonist naloxone (NAL, 1.0 mg/kg, ip), or vehicle. On days 1, 7 and 10 after the injections, mice were assessed in activity cages at different times (15, 30, 45 and 60 min) for 5 min. The acute combination of EtOH plus DEP induced a significantly higher increase in locomotor activity (day 1: 369.5 + or - 34.41) when compared to either drug alone (day 1: EtOH = 232.5 + or - 23.79 and DEP = 276.0 + or - 12.85) and to control solution (day 1: 153.12 + or - 7.64). However, the repeated administration of EtOH (day 7: 314.63 + or - 26.79 and day 10: 257.62 + or - 29.91) or DEP (day 7: 309.5 + or - 31.65 and day 10: 321.12 + or - 39.24) alone or in combination (day 7: 459.75 + or - 41.28 and day 10: 427.87 + or - 33.0) failed to induce a progressive increase in the locomotor response. These data demonstrate greater locomotion-activating effects of the EtOH + DEP combination, probably involving DA and/or opioid receptor stimulation, since the daily pretreatment with HAL (day 1: EtOH + DEP = 395.62 + or - 11.92 and EtOH + DEP + HAL = 371.5 + or - 6.76; day 7: EtOH + DEP = 502.5 + or - 42.27 and EtOH + DEP + HAL = 281.12 + or - 16.08; day 10: EtOH + DEP = 445.75 + or - 16.64 and EtOH + DEP + HAL = 376.75 + or - 16.4) and NAL (day 1: EtOH + DEP = 553.62 + or - 38.15 and EtOH + DEP + NAL = 445.12 + or - 55.67; day 7: EtOH + DEP = 617.5 + or - 38.89 and EtOH + DEP + NAL = 418.25 + or - 61.18; day 10: EtOH + DEP = 541.37 + or - 32.86 and EtOH + DEP + NAL = 427.12 + or - 51.6) reduced the locomotor response induced by combined administration of EtOH + DEP. These findings also suggest that a major determinant of combined anorectic-alcohol misuse may be the increased stimulating effects produced...


Assuntos
Animais , Masculino , Camundongos , Depressores do Apetite/farmacologia , Dietilpropiona/farmacologia , Antagonistas de Dopamina/farmacologia , Etanol/farmacologia , Atividade Motora/efeitos dos fármacos , Receptores Opioides/antagonistas & inibidores , Haloperidol/farmacologia , Naloxona/farmacologia , Antagonistas de Entorpecentes/farmacologia
7.
Indian J Physiol Pharmacol ; 1997 Jul; 41(3): 275-9
Artigo em Inglês | IMSEAR | ID: sea-106696

RESUMO

Stress is known to produce analgesia. The pain threshold is altered in diabetes. We studied the effect of 1 hr of immobilisation stress on pain threshold in male Wistar rats. The same effect was tested in streptozotocin induced diabetic rats. The pain threshold of tail flick, vocalisation and vocalisation after discharge increased in the control group after the stress procedure. Significant analgesia was also obtained in diabetic rats, for flick and after discharge pain threshold. However the vocalisation threshold was not altered, probably due to the antagonistic action of glucose on opiate receptor at the level of brain stem.


Assuntos
Analgesia , Animais , Glicemia/metabolismo , Tronco Encefálico/metabolismo , Diabetes Mellitus Experimental/induzido quimicamente , Imobilização , Masculino , Limiar da Dor , Ratos , Ratos Wistar , Receptores Opioides/antagonistas & inibidores , Estreptozocina , Estresse Fisiológico/complicações , Vocalização Animal
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA